Tziomalos Konstantinos, Athyros Vasilios G, Karagiannis Asterios, Mikhailidis Dimitri P
Second Propedeutic Department of Internal Medicine, Aristotle University, Hippokration Hospital, 63 Solonos Street, Thessaloniki, 54248, Greece.
Curr Atheroscler Rep. 2008 Dec;10(6):510-7. doi: 10.1007/s11883-008-0079-y.
Omega-3 fatty acids (FAs) are divided into long-chain fatty acids (eicosapentaenoic acid and docosahexaenoic acid ), which are found in fatty fish, and intermediate-chain FAs (alpha-linolenic acid), which are found in vegetable oils. Omega-3 FAs favorably modulate a variety of vascular risk factors and also exert antiarrhythmic effects. Epidemiologic data suggest that increased consumption of marine omega-3 FAs is associated with reduced coronary heart disease (CHD) mortality. Randomized controlled studies also show that supplementation with EPA and DHA reduces CHD risk, primarily in the secondary prevention setting. Data are more limited on the efficacy of marine omega-3 FAs for the primary prevention of CHD and on the role of alpha-linolenic acid. Increased intake of EPA and DHA represents a valuable tool for vascular disease prevention and should be recommended in all patients with CHD.
欧米伽-3脂肪酸(FAs)分为长链脂肪酸(二十碳五烯酸和二十二碳六烯酸),存在于富含脂肪的鱼类中,以及中链脂肪酸(α-亚麻酸),存在于植物油中。欧米伽-3脂肪酸可有效调节多种血管危险因素,还具有抗心律失常作用。流行病学数据表明,增加海洋来源的欧米伽-3脂肪酸摄入量与降低冠心病(CHD)死亡率相关。随机对照研究也表明,补充二十碳五烯酸(EPA)和二十二碳六烯酸(DHA)可降低冠心病风险,主要用于二级预防。关于海洋来源的欧米伽-3脂肪酸用于冠心病一级预防的疗效以及α-亚麻酸的作用的数据更为有限。增加二十碳五烯酸和二十二碳六烯酸的摄入量是预防血管疾病的一项重要手段,应推荐给所有冠心病患者。